Larimar Therapeutics, Inc.·4

May 20, 8:02 PM ET

DEERFIELD MANAGEMENT COMPANY, L.P. 4

4 · Larimar Therapeutics, Inc. · Filed May 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Larimar (LRMR) 10% Owner James E. Flynn Receives 55,150-Share Award

What Happened James E. Flynn (reported as a 10% owner / reporting person) filed a Form 4 reporting a derivative award on May 19, 2026: an option-like grant covering 55,150 shares at a reported price of $0.00 (transaction code A — grant/award). The filing’s footnotes state the option was granted to director Jonathan S. Leff and is held for the benefit and at the direction of Deerfield Management Company, L.P.; Flynn is filing because of his role as sole member of the GP of Deerfield Management. No cash was paid in this reported grant.

Key Details

  • Transaction date: 2026-05-19; Form 4 filed: 2026-05-20 (timely).
  • Type: Grant/award (derivative option) — 55,150 shares, $0.00 reported price.
  • Vesting: Option vests on the earlier of May 19, 2027 or the issuer’s next annual meeting, subject to continued board service (per footnote).
  • Beneficial ownership after transaction: not specified in the summary provided (see the full Form 4 for post-transaction holdings).
  • Footnotes: F1–F3 clarify the option was granted to director Jonathan S. Leff, held for Deerfield Management’s benefit; Flynn disclaims direct beneficial ownership except for any indirect pecuniary interest; a POA/Attorney-in-Fact is referenced.
  • Timeliness: Filing appears timely (filed one day after the reported transaction date).

Context This is a compensation-related derivative grant (an option award) rather than an open-market buy or sale, so it reflects board/compensation activity more than a direct trading signal. Because the award is held for the benefit and at the direction of Deerfield Management and the reporting person is a 10% owner/institutional affiliate, this is institutional/investment-firm-related reporting rather than a typical insider purchase or sale by an executive.

Insider Transaction Report

Form 4
Period: 2026-05-19
Flynn James E
Director10% OwnerOther
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1][F2][F3]
    2026-05-19+55,15055,150 total(indirect: Through Deerfield Management Company, L.P.)
    Exercise: $3.33Exp: 2036-05-19Common Stock (55,150 underlying)
Footnotes (3)
  • [F1]Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management").
  • [F2]The option was granted on May 19, 2026 and is scheduled to vest on the earlier of May 19, 2027 and the date of the Issuer's next annual meeting of stockholders, in each case, subject to Jonathan S. Leff 's continued service on the board of directors of the Issuer.
  • [F3]This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
Signature
/s/ Jonathan Isler, Attorney-in-Fact|2026-05-20

Documents

2 files